A 30-second interval was allowed between the two trials at the given speed.
Parallels between the two trials were striking, he said.
In between the two trials, though, the legal ground had shifted.
However, they received a 40-second "microbreak" in between the two trials.
The differences between the two trials suggest that the process design greatly influences the final product.
Since differences in the long-term outcomes between the two trials were observed to be not statistically significant, a combined analysis of the two cohorts was done.
Before the exercise, there was no significant difference for any blood variables between the two trials.
However, the fruit rind netting characters (i.e., ND and NW) were relatively consistent between the two trials.
Moreover, no significant difference in repeated sprint ability was observed between the two trials at any time points.
Moreover, repeated sprint ability did not differ significantly between the two trials during Ex2 (at 4 h after completing Ex1) or at 24 h during post-exercise period.
In contrast, there were no significant differences between the two trials at 24 h during post-exercise period for serum CK, Mb, leptin, and plasma IL-6 concentrations.
